ArticleScientific reports2025
Drug-drug interaction prediction of traditional Chinese medicine based on graph attention networks.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Computational approaches for drug-drug interaction prediction: a systematic review of data sources, modeling strategies, and evaluation frameworks.Frontiers in pharmacology · 2026Pooled it
- Pharmacokinetic Prediction of Repurposed Drugs for PDAC Using Artificial Intelligence.ACS omega · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Predicting drug-drug interactions (DDI) is crucial for preventing adverse reactions in patients and plays a vital role in drug design and development. However, traditional Chinese medicine (TCM) formulations, typically composed of multiple herbal ingredients with diverse bioactive compounds, present a unique challenge in comprehensively assessing potential adverse interactions among their components. To address this challenge, we propose a novel Dual Graph Attention Network (DGAT) designed to predict TCM drug-drug interactions (TCMDDI) by extracting key structural features of active molecules within the herbal ingredients. Our approach leverages graph-based representations of chemical molecules and employs attention mechanism to extract deep structural features, enabling the effective prediction of TCMDDI by capturing spatial structural relationships among different compounds. Furthermore, we construct a comprehensive dataset encompassing three different categories of herbal ingredients, informed by traditional TCM principles. Experimental results reveal that the proposed DGAT method significantly outperforms currently advanced deep learning techniques, including Graph Convolutional Networks, Weave, and Message Passing Neural Networks. Compared to traditional rule-based two-dimensional molecular descriptors, DGAT more effectively captures the spatial structural information of molecules. Notably, DGAT exhibits robust performance and strong generalizability on unseen samples, providing valuable insights for future research on TCMDDI prediction and advancing the integration of artificial intelligence in TCM studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.